The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.
What Market Size Growth Is Projected For The Cell Therapy Raw Materials Market During The Forecast Period 2026–2030?
The cell therapy raw materials market size has shown significant expansion in recent years. This market is anticipated to increase from $5.07 billion in 2025 to $6.1 billion in 2026, achieving a compound annual growth rate (CAGR) of 20.4%. The historical rise in this market can be linked to the early-stage development of cell therapies, reliance on animal-derived sera, limited scalability of cell culture processes, growing academic and clinical research in cell therapy, and increasing investment in regenerative medicine.
The cell therapy raw materials market size is poised for significant expansion in the upcoming years. It is projected to reach $12.75 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 20.2%. This anticipated growth during the forecast period stems from factors such as the successful commercialization of cell and gene therapies, the increasing need for car-t treatments, innovations in cell expansion and cryopreservation materials, stricter regulatory oversight concerning raw material quality, and the overall expansion of biopharmaceutical manufacturing capabilities. Key developments anticipated during this period encompass a heightened demand for consistent and high-quality cell culture media, a greater uptake of serum-free and chemically defined raw materials, an expanding manufacturing pipeline for car-t and gene therapies, an increase in outsourcing to specialized raw material providers, and a stronger emphasis on regulatory compliance and product traceability.
Download the Free Sample Report to Explore Key Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27245&type=smp
Which Major Factors Are Driving The Expansion Of The Cell Therapy Raw Materials Market?
The expanding application of regenerative medicine is anticipated to drive the advancement of the cell therapy raw materials market in the future. Regenerative medicine defines a medical discipline focused on re-establishing or restoring natural function through the replacement, engineering, or regeneration of human cells, tissues, or organs. The prevalence of regenerative medicine is on the rise, primarily owing to the increasing impact of chronic and degenerative diseases, which necessitate therapies capable of repairing or substituting compromised tissues instead of merely addressing symptoms. These cell therapy raw materials contribute significantly to the progress of regenerative medicine by supplying vital constituents like growth factors, cell culture media, enzymes, and scaffolds, which are crucial for the cultivation, expansion, and upkeep of therapeutic cells utilized for repairing or regenerating impaired tissues and organs. As an illustration, in January 2025, the National Library of Medicine, a US-based biomedical library, disclosed that 32 novel gene therapies, encompassing genetically modified cell therapies, received approval in 2024. Consequently, the increasing adoption of regenerative medicine is fueling the expansion of the cell therapy raw materials market.
What Market Segments Are Evaluated Within The Cell Therapy Raw Materials Market?
The cell therapy raw materials market covered in this report is segmented –
1) By Therapy Area: Stem Cell Based Raw Materials, Gene Therapy Raw Materials, CAR-T Cell Therapy Raw Materials
2) By Product Type: Media, Sera, Cell Culture Supplements, Antibodies, Reagents And Buffers, Other Product Types
3) By End User: Biopharmaceutical And Pharmaceutical Companies, Contract Research Organization And Contract Manufacturing Organization, Other End Users
Subsegments:
1) By Stem Cell Based Raw Materials: Growth Factors, Cytokines, Cell Culture Media
2) By Gene Therapy Raw Materials: Transfection Reagents, Nucleotides And Enzymes, Cell Culture Media For Gene Modification
3) By Car-T Cell Therapy Raw Materials: T Cell Activation Reagents, Cell Expansion Media, Cryopreservation Agents
What Industry Trends Are Redefining The Cell Therapy Raw Materials Market?
Leading companies within the cell therapy raw materials market are concentrating on creating innovative solutions, including good manufacturing practice (GMP)-compliant manufacturing, to guarantee product safety, uniformity, and regulatory adherence throughout the cell therapy production process. This good manufacturing practice (GMP)-compliant manufacturing system ensures products are consistently produced and managed in line with quality standards set by regulatory authorities, aiming to mitigate risks in pharmaceutical and biotechnological production. For instance, in April 2025, Thermo Fisher Scientific Inc., a US-based American life science and clinical research company, launched a US advanced therapies collaboration center (ATxCC) to bolster the development and commercialization of cell and gene therapies. The center accelerates cell therapy development by offering comprehensive cGMP manufacturing support, advanced technologies, and expert process optimization, thereby fostering collaboration to overcome manufacturing challenges and expedite commercialization.
Who Are The Top Market Participants Influencing The Cell Therapy Raw Materials Market?
Major companies operating in the cell therapy raw materials market are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Lonza Group AG, Sartorius Stedim Biotech SA, Bio-Techne Corporation, Stemcell Technologies Inc., Miltenyi Biotec GmbH, ACROBiosystems Co Ltd., CellGenix GmbH, Promocell GmbH, RoosterBio Inc., Akron Biotech LLC.
Read the full cell therapy raw materials market report here:
https://www.thebusinessresearchcompany.com/report/cell-therapy-raw-materials-global-market-report
Which Region Currently Holds The Largest Share Of The Cell Therapy Raw Materials Market?
North America was the largest region in the cell therapy raw materials market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the cell therapy raw materials market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Tailored Cell Therapy Raw Materials Market Research Report For Competitive Advantage:
https://www.thebusinessresearchcompany.com/customise?id=27245&type=smp
Browse Through More Reports Similar to the Global Cell Therapy Raw Materials Market 2026, By The Business Research Company
Wooden Interior Door Market Report 2026
https://www.thebusinessresearchcompany.com/report/wooden-interior-door-global-market-report
Aluminum Doors And Windows Market 2026
https://www.thebusinessresearchcompany.com/report/aluminum-doors-and-windows-market
Aluminum Doors And Windows Market Report 2026
https://www.thebusinessresearchcompany.com/report/aluminum-doors-and-windows-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model